Trial Profile
Effect of subcutaneous treprostinil in patients with post-capillary pulmonary hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 19 Dec 2015 New trial record